Fax: (802) 656-8826
Original Article
Socioeconomic status and survival after an invasive breast cancer diagnosis
Article first published online: 8 NOV 2010
DOI: 10.1002/cncr.25589
Copyright © 2010 American Cancer Society
Additional Information
How to Cite
Sprague, B. L., Trentham-Dietz, A., Gangnon, R. E., Ramchandani, R., Hampton, J. M., Robert, S. A., Remington, P. L. and Newcomb, P. A. (2011), Socioeconomic status and survival after an invasive breast cancer diagnosis. Cancer, 117: 1542–1551. doi: 10.1002/cncr.25589
- ‡
Fax: (802) 656-8826
- §
We are grateful to Drs. Kathleen Egan, Linda Titus-Ernstoff, Henry Anderson, and Jane McElroy for study-related advice; to Laura Stephenson and the staff of the Wisconsin Cancer Reporting System; and to Julie McGregor, Kathy Peck, Mary Pankratz, Linda Haskins, and Jerry Phipps along with the study interviewers for assistance with data collection.
Publication History
- Issue published online: 18 MAR 2011
- Article first published online: 8 NOV 2010
- Manuscript Accepted: 20 JUL 2010
- Manuscript Revised: 28 JUN 2010
- Manuscript Received: 3 MAY 2010
REFERENCES
- 1, , , et al. SEER Cancer Statistics Review, 1975-2006. Bethesda, MD: National Cancer Institute; 2008. http://seer.cancer.gov/csr/1975_2006/based on November 2008 SEER data submission, posted to the SEER website, 2009. Accessed on October 13, 2010.
- 2, , , et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005; 353: 1784-1792.
- 3Estimates of lead time and length bias in a breast cancer screening program. Cancer. 1980; 46: 844-851.
- 4, , , et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer. 2004; 101: 3-27.
- 5, , , , , Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005). Cancer Epidemiol Biomarkers Prev. 2009; 18: 121-131.
- 6, , , et al. The impact of socioeconomic status on survival after cancer in the United States: findings from the National Program of Cancer Registries Patterns of Care Study. Cancer. 2008; 113: 582-591.
- 7Socioeconomic disparities in breast cancer survival: relation to stage at diagnosis, treatment and race [serial online]. BMC Cancer. 2009; 9: 364.
- 8, , , Socioeconomic factors and race in breast cancer recurrence and survival. Am J Epidemiol. 1992; 135: 609-618.
- 9, Social class and black-white differences in breast cancer survival. Am J Public Health. 1986; 76: 1400-1403.
- 10, , , , Breast cancer survival in Ontario and California, 1998-2006: socioeconomic inequity remains much greater in the United States. Ann Epidemiol. 2009; 19: 121-124.
- 11
- 12, Disparities across the breast cancer continuum. Cancer Causes Control. 2005; 16: 35-44.
- 13, , Race, socioeconomic status, and breast carcinoma in the US: what have we learned from clinical studies. Cancer. 2002; 95: 1988-1999.
- 14, , , et al. Socioeconomic status in health research: 1 size does not fit all. JAMA. 2005; 294: 2879-2888.
- 15, Socioeconomic factors and breast carcinoma in multicultural women. Cancer. 2000; 88( 5 suppl): 1256-1264.
- 16, The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review. J Womens Health (Larchmt). 2009; 18: 883-893.
- 17Socioeconomic position and health: the independent contribution of community socioeconomic context. Annu Rev Sociol. 1999; 25: 489-516.
- 18, , , , , Lifetime recreational and occupational physical activity and risk of in situ and invasive breast cancer. Cancer Epidemiol Biomarkers Prev. 2007; 16: 236-243.
- 19, , , A case-control study of the HER2 Ile655Val polymorphism in relation to risk of invasive breast cancer. Breast Cancer Res. 2005; 7: R357-R364.
- 20US Census Bureau. 2000 Census of Population and Housing, Summary File 3: Washington, DC: US Census Bureau; 2002. http://www.census.gov/census2000/sumfile3.html. Accessed on October 13, 2010.
- 21, , , , Geocoding addresses from a large population-based study: lessons learned. Epidemiology. 2003; 14: 399-407.
- 22, , , et al. Socioeconomic risk factors for breast cancer: distinguishing individual- and community-level effects. Epidemiology. 2004; 15: 442-450.
- 23, , , et al. International Classification of Diseases for Oncology, 3rd Edition., Geneva, Switzerland: World Health Organization; 2000.
- 24, Utility of the National Death Index for ascertainment of mortality among cancer prevention study II participants. Am J Epidemiol. 1993; 137: 235-241.
- 25World Health Organization. International Classification of Diseases, 9th Revision (ICD-9). Geneva, Switzerland: World Health Organization; 1977.
- 26World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10). Geneva, Switzerland: World Health Organization; 1994.
- 27United States Department of Health and Human Services, Office of the Secretary. Annual update of the HHS Poverty Guidelines. Fed Reg. 2000; 65: 7555-7557.
- 28
- 29
- 30, The robust inference for the proportional hazards model. J Am Stat Assoc. 1989; 84: 1074-1078.
- 31, Survival Analysis: Techniques for Censored and Truncated Data. New York: Springer; 1997.
- 32, Use of census-based aggregate variables to proxy for socioeconomic group: evidence from national samples. Am J Epidemiol. 1998; 148: 475-486.
- 33, , , The relation between health insurance coverage and clinical outcomes among women with breast cancer. N Engl J Med. 1993; 329: 326-331.
- 34, , Disparities in cancer diagnosis and survival. Cancer. 2001; 91: 178-188.
- 35, , Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst. 2002; 94: 490-496.
- 36, , , , Effects of race and socioeconomic status on survival of 1332 black, Hispanic, and white women with breast cancer. Ann Surg Oncol. 1997; 4: 111-118.
- 37National Center for Health Statistics. Health, United States, 2008 with Chartbook, 2008. Hyattsville, Md: National Center for Health Statistics; 2008.
- 38, , Breast cancer screening in the United States and Canada, 1994: socioeconomic gradients persist. Am J Public Health. 2000; 90: 799-803.
- 39, , , , Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer. 2003; 97: 1528-1540.
- 40, , , , Neighborhood-level socioeconomic predictors of nonadherence to mammography screening guidelines. Cancer Epidemiol Biomarkers Prev. 2007; 16: 2293-2303.
- 41, , , et al. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the Surveillance, Epidemiology, and End Results National Longitudinal Mortality Study. Cancer Causes Control. 2009; 20: 417-435.
- 42, , , et al. Factors associated with advanced disease stage at diagnosis in a population-based study of patients with newly diagnosed breast cancer. Am J Epidemiol. 2007; 166: 1035-1044.
- 43, , , , , Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer. JAMA. 1998; 279: 1801-1807.
- 44, , , et al. Evidence of a healthy volunteer effect in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Epidemiol. 2007; 165: 874-881.
- 45, , , , A case-control evaluation of the effect of breast cancer screening in the United Kingdom trial of early detection of breast cancer. J Epidemiol Commun Health. 1992; 46: 362-364.
- 46, , , et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003; 289: 76-79.
- 47, , , , An overview of prognostic factors for long-term survivors of breast cancer. Breast Cancer Res Treat. 2008; 107: 309-330.
- 48, , , et al. Prediagnostic use of hormone therapy and mortality after breast cancer. Cancer Epidemiol Biomarkers Prev. 2008; 17: 864-871.
- 49, , , et al. Estrogen replacement therapy and breast cancer survival in a large screening study. J Natl Cancer Inst. 1999; 91: 264-270.
- 50Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005; 365: 1687-1717.
- 51, , , , Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California Cancer Registry. Cancer. 2007; 109: 1721-1728.
- 52, A critical look at methods for handling missing covariates in epidemiologic regression analyses. Am J Epidemiol. 1995; 142: 1255-1264.

1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
